Clinical Trials · NCT02351128
Treatment of Unresecable and/or Metastatic Merkel Cell Carcinoma by Somatostatine Analogues
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- University Hospital, Grenoble
- Enrollment
- 35
- Start date
- Apr 2015
- Locations
- 1 site, France
- Primary endpoint
- Percentage of patient with positive response according to the RECIST 1.1 criteria